increasing adoption of innovative marketing strategies is driving the Female Contraceptive Market
Technavio analyzes that the Female Contraceptive Market is expected to grow at a CAGR of 4.6% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 4571.5 million.There are various factors that contribute to the growth of the market. The female contraceptive market is witnessing significant growth due to the increasing adoption of innovative marketing strategies. Companies are leveraging digital platforms, social media, and targeted advertising to reach potential customers. Additionally, the development of new and effective contraceptive methods continues to drive demand. These factors are contributing to the expansion of the market and the introduction of new products. Overall, the female contraceptive market is poised for continued growth in the coming years.
In the female contraceptive market, merchandisers, including specialty stores, hypermarkets, supermarkets, and convenience stores, are experiencing growth due to increasing consumer awareness and availability of various contraceptive options. These options encompass intrauterine devices (IUDs), hormonal and non-hormonal intrauterine devices, subcutaneous implants, and late-stage pipeline therapies. Merchandisers are broadening their product offerings to include sexual wellness categories, such as condoms, contraceptives, personal lubricants, vibrators, and sexual enhancement supplements. Expansion into local and regional markets is a strategic move to boost sales through offline channels. Key contraceptive classes, such as hormonal and non-hormonal, face ongoing challenges related to adverse reactions and compliance and adherence. Despite these challenges, the market is projected to grow steadily, driven by the demand for effective and accessible birth control solutions. Drug developers continue to innovate, addressing these challenges through the development of new technologies and formulations.
Know which region is leading the market growth by requesting a sample report
Female Contraceptive Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
The female contraceptive market caters to the needs of the female population through various contemporary methods, including intrauterine devices (IUDs) and oral contraceptives. The contraceptive pipeline is robust, with new offerings such as Dienogest + ethinylestradiol PR and Estelle (drospirenone + estetrol). Drospirenone is also used in oral contraceptives and transdermal patches. Female vitiligo patients and those at risk of osteoporosis require special consideration. A patient enrolment milestone was reached in a study on oral contraceptives' success. Topical contraceptives like vaginal gels, transdermal patches, and spermicides, as well as medications like contraceptive injections, diaphragms, and caps, are also available. Birth control methods include surgery, but most prefer medications. Unplanned births among teenagers and young population remain a concern, highlighting the importance of accessible and effective contraceptive options.
The Female Contraceptive Market is a significant segment within the broader Global Personal Care Products industry. Key products include Intrauterine Devices (IUDs) and oral contraceptives, which cater to the reproductive health needs of a substantial portion of the global female population. The contraceptive pipeline features innovative offerings, such as Estelle (drospirenone + estetrol), which differentiates from traditional oral contraceptives containing drospirenone. However, considerations for specific patient populations, such as those with vitiligo or osteoporosis, necessitate ongoing research and development. Milestones, such as successful patient enrolment in clinical trials, are crucial indicators of progress in the oral contraceptives market. Additionally, alternative delivery methods, including transdermal patches and vaginal gels, expand the contraceptive drugs landscape. The market's growth is influenced by increasing disposable income, enabling greater expenditure on personal and lifestyle-related products.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
